Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, DB, Parallel Group, MC Study to Evaluate the Efficacy and Safety of Four Doses of Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depigoid Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma

NCT01144429 is registered in ClinicalTrials.gov with Leti Pharma GmbH as lead sponsor.

NCT NCT01144429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, DB, Parallel Group, MC Study to Evaluate the Efficacy and Safety of Four Doses of Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depigoid Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma
Lead sponsor
Leti Pharma GmbH
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
May 31, 2011
Enrollment
344 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis and/or rhinoconjunctivitis +- asthma, immunotherapy, allergen